Croda International (LON:CRDA) Stock Rating Upgraded by JPMorgan Chase & Co.

Croda International (LON:CRDA - Get Free Report) was upgraded by equities researchers at JPMorgan Chase & Co. to an "overweight" rating in a research report issued on Wednesday, Marketbeat.com reports.

Other equities research analysts have also issued reports about the stock. Citigroup cut their price target on shares of Croda International from GBX 3,550 ($47.12) to GBX 3,300 ($43.80) and set a "neutral" rating on the stock in a research note on Tuesday, April 29th. Berenberg Bank reiterated a "buy" rating and set a GBX 3,800 ($50.44) price target on shares of Croda International in a research note on Thursday, April 24th.

Croda International Trading Up 0.6%

Shares of CRDA traded up GBX 15 ($0.20) during midday trading on Wednesday, reaching GBX 2,627 ($34.87). The company had a trading volume of 536,042 shares, compared to its average volume of 1,088,552. Croda International has a 1-year low of GBX 2,527 ($33.54) and a 1-year high of GBX 4,335 ($57.54). The stock has a market cap of £3.67 billion, a PE ratio of 22.57, a price-to-earnings-growth ratio of 1.40 and a beta of 0.74. The firm has a 50 day simple moving average of GBX 2,967.84 and a 200-day simple moving average of GBX 3,025.97. The company has a quick ratio of 2.25, a current ratio of 2.72 and a debt-to-equity ratio of 30.90.

Croda International (LON:CRDA - Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The company reported GBX 72.20 ($0.96) earnings per share for the quarter. Croda International had a return on equity of 6.96% and a net margin of 9.98%. Research analysts forecast that Croda International will post 181.8307268 EPS for the current fiscal year.

Insider Buying and Selling

In other news, insider Stephen Oxley acquired 3,762 shares of the company's stock in a transaction dated Tuesday, July 29th. The stock was acquired at an average cost of GBX 2,671 ($35.45) per share, for a total transaction of £100,483.02 ($133,372.74). Also, insider Tom Brophy purchased 90 shares of the stock in a transaction that occurred on Thursday, May 29th. The shares were purchased at an average cost of GBX 3,070 ($40.75) per share, with a total value of £2,763 ($3,667.37). In the last ninety days, insiders purchased 6,346 shares of company stock valued at $17,310,982. 0.93% of the stock is owned by insiders.

Croda International Company Profile

Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world.